Main Article Content

Putri Jati Utami
Prasetyadi Mawardi
Utiya Nur Laili
Larisa Sabrina Rahadiyanti

Page: 2362-2366

Abstract

Thyroid carcinoma is one of the most common endocrine cancers with a multi-factorial etiology. The role of HSV-1 in the pathogenesis of thyroid cancer remains an area of ongoing investigation. HSV-1 may be present in thyroid tissue raising questions about its potential role in thyroid carcinogenesis. The first case involves a 65-year-old male diagnosed with thyroid carcinoma, presenting with a history of oral discomfort and pain two weeks before evaluation. The second case is a 73-year-old male, also diagnosed with thyroid carcinoma with no history of herpes simplex virus (HSV). Both patients underwent thyroidectomy, and histopathological examination confirmed the presence of papillary carcinoma in thyroid tissue. Immunohistochemical analysis further identified HSV-1 in both cases. A study has reported a higher frequency of HSV DNA detection in thyroid carcinoma, with a significant correlation between oncogenic mutations and HSV presence. The upregulation of nectin-1 expression in thyroid carcinoma facilitates HSV occurrence, thereby increasing the susceptibility of cancer cells to viral infection. Moreover, thyroid hormone levels may play a role in HSV reactivation, highlighting the intricate interplay between thyroid function, viral activity, and cancer progression. Histopathological examination, including immunohistochemical (IHC) staining, identified HSV 1 in two patients diagnosed with thyroid carcinoma. These findings underscore the need for further research involving a larger cohort to elucidate the potential role of HSV in thyroid carcinogenesis.

Downloads

Download data is not yet available.

Article Details

How to Cite
Utami, P. J., Mawardi, P., Laili, U. N., & Rahadiyanti, L. S. (2026). Immunohistochemical Features of Herpes Simplex Virus Type 1 Infection in Patients with Thyroid Carcinoma: A Case Series. Journal of Pharmaceutical and Sciences, 9(3), 2362–2366. https://doi.org/10.36490/journal-jps.com.v9i3.1603
Section
Original Articles

References

El-Habashy DM. Characteristics of patients with thyroid carcinoma in the United States. Ann Oncol. 2019;30:v195.

Kiran N, Adeel B, Abbasi MK, Malik AI, Aslam N, Sharif S. Histopathological characteristics and incidence of thyroid carcinoma in a tertiary care hospital of Pakistan - A retrospective study. Pak J Med Health Sci. 2022;16:230–2.

Kruger E, Toraih EA, Hussein MH, Shehata SA, Waheed A, Fawzy MS, et al. Thyroid carcinoma: A review for 25 years of environmental risk factors studies. Cancers. 2022;14:6172.

Teixeira ES, Nascimento M, Leao SLS. Influence of NECTIN1 gene variants in herpesvirus infection in patients with thyroid nodules. Cancer Med J. 2022;5.

Crimi S, Fiorillo L, Bianchi A, D’Amico C, Amoroso G, Gorassini F, et al. Herpes virus, oral clinical signs and qol: Systematic review of recent data. Viruses. 2019;11:463.

Shetty M, Sara John D, Durgapal S, Shetty U. Herpes simplex virus: A case report and review of literature. Biomedicine. 2023;43:1076–9.

McQuillan G, Kruszon-Moran D, Flagg EW, Paulose-Ram R. Prevalence of herpes simplex virus type 1 and type 2 in persons aged 14-49: United States, 2015-2016. NCHS Data Brief. 2018;1–8.

Harrison KS, Zhu L, Thunuguntla P, Jones C. Herpes simplex virus 1 regulates β-catenin expression in TG neurons during the latency-reactivation cycle. PLoS One. 2020;15:e0230870.

Jensen K, Patel A, Larin A, Hoperia V, Saji M, Bauer A, dkk. Human herpes simplex viruses in benign and malignant thyroid tumours. J Pathol. 2010;221:193–200.

Figliozzi RW, Chen F, Hsia SV. New insights on thyroid hormone mediated regulation of herpesvirus infections. Cell Biosci. 2017;7:13.

Yun H, Jeon JS, Kim JK. Analysis of inflammatory and thyroid hormone levels based on hepatitis a and b virus immunity status: Age and sex stratification. Viruses. 2024;16:1329.

De Luca R, Davis PJ, Lin HY, Gionfra F, Percario ZA, Affabris E, dkk. Thyroid hormones interaction with immune response, inflammation and non-thyroidal illness syndrome. Front Cell Dev Biol. 2021;8.

Crescenzi A, Baloch Z. Immunohistochemistry in the pathologic diagnosis and management of thyroid neoplasms. Front Endocrinol. 2023;14.

Abu-Seadah S, Attiah S, Ali M, Shams El-Din M, El-Kholy M. Immunohistochemical expression of HBME-1 and TROP-2 in some follicular-derived thyroid lesions. Asian Pac J Cancer Prev. 2023;24:2305–11.

Faten L, Anis R, Thomas M. Papillary thyroid carcinoma. Treasure island: StatPearls Publishing; 2024.

Sun Y, Dai W, Liang Y, Xia N. Impact of age on the prognosis of papillary thyroid carcinoma. Arch Iran Med. 2020;23:169–74.

Kitahara CM, Schneider AB. Epidemiology of thyroid cancer. CEBP. 2022;31:1284–97.

Hayaza SS, Wahyudi BRS, Triani E. Carcinoma thyroid : A literature review. JBT. 2024;24:696–702.

Gopinath D, Koe KH, Maharajan MK, Panda S. A Comprehensive overview of epidemiology, pathogenesis and the management of herpes labialis. Viruses. 2023;15:225.

James C, Harfouche M, Welton NJ, Turner KM, Abu-Raddad LJ, Gottlieb SL, dkk. Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bull World Health Organ. 2020;98:315–29.

David G. Thyroid cancer. Emedicine Medscape. 2021.

Kenny L, Catherine A, Chandriya C, Sebastiano C. Thyroid cancer. Treasure Island: StatPearls Publishing; 2023.

Hu J, Yuan IJ, Mirshahidi S, Simental A, Lee SC, Yuan X. Thyroid carcinoma: Phenotypic features, underlying biology and potential relevance for targeting therapy. Int J Mol Sci. 2021;22:1950.

Laval K, Enquist LW. The potential role of herpes simplex virus type 1 and neuroinflammation in the pathogenesis of alzheimer’s disease. Front Neurol. 2021;12.

Biocare Medical. A simple solution to identifying herpes simplex 1 & 2 through immunohistochemistry. New York; 2020.

Sexually Transmitted Infections Education Foundation (STIEF). Testing for herpes. NZ Herpes Foundation; 2025.